Works matching IS 20590105 AND DT 2024 AND VI 9 AND IP 1
Results: 255
Replicating RNA vaccine confers durable immunity against Crimean Congo hemorrhagic fever virus challenge in mice.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-01045-1
- By:
- Publication type:
- Article
Co-immunization with spike and nucleocapsid based DNA vaccines for long-term protective immunity against SARS-CoV-2 Omicron.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-01043-3
- By:
- Publication type:
- Article
Boosting neuraminidase immunity in the presence of hemagglutinin with the next generation of influenza vaccines.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-01011-x
- By:
- Publication type:
- Article
The dengue-specific immune response and antibody identification with machine learning.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-01027-3
- By:
- Publication type:
- Article
DS2 designer pre-fusion F vaccine induces strong and protective antibody response against RSV infection.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-01059-9
- By:
- Publication type:
- Article
Modeling the persistence of 4CMenB vaccine protection against real world meningococcal B disease in adolescents.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-01025-5
- By:
- Publication type:
- Article
Immunogenicity and safety of the 15-valent pneumococcal conjugate vaccine, a systematic review and meta-analysis.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-01048-y
- By:
- Publication type:
- Article
Mpox mRNA-1769 vaccine inhibits orthopoxvirus replication at intranasal, intrarectal, and cutaneous sites of inoculation.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-01052-2
- By:
- Publication type:
- Article
A Phase 1 randomized trial of homologous and heterologous filovirus vaccines with a late booster dose.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-01042-4
- By:
- Publication type:
- Article
Systematic review of the impact of intestinal microbiota on vaccine responses.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-01000-0
- By:
- Publication type:
- Article
The adjuvant effect of manganese on tuberculosis subunit vaccine Bfrb-GrpE.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-01049-x
- By:
- Publication type:
- Article
A safe insect-based chikungunya fever vaccine affords rapid and durable protection in cynomolgus macaques.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-01047-z
- By:
- Publication type:
- Article
SPA14 liposomes combining saponin with fully synthetic TLR4 agonist provide adjuvanticity to hCMV vaccine candidate.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-01046-0
- By:
- Publication type:
- Article
Persistence of hepatitis E vaccine-induced antibody response across different dosage schedules and baseline serostatus.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-01041-5
- By:
- Publication type:
- Article
Use of equine H3N8 hemagglutinin as a broadly protective influenza vaccine immunogen.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-01037-1
- By:
- Publication type:
- Article
Immunogenic recombinant Mayaro virus-like particles present natively assembled glycoprotein.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-01021-9
- By:
- Publication type:
- Article
Publisher Correction: The dengue-specific immune response and antibody identification with machine learning.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Establishing an immune correlate of protection for Nipah virus in nonhuman primates.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-01036-2
- By:
- Publication type:
- Article
Intranasal influenza-vectored vaccine expressing pneumococcal surface protein A protects against Influenza and Streptococcus pneumoniae infections.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-01033-5
- By:
- Publication type:
- Article
Downregulation of IRF7-mediated type-I interferon response by LmCen<sup>–/–</sup> parasites is necessary for protective immunity.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-01032-6
- By:
- Publication type:
- Article
Potent and long-lasting humoral and cellular immunity against varicella zoster virus induced by mRNA-LNP vaccine.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-00865-5
- By:
- Publication type:
- Article
Identifying Plasmodium P36 and P52 antigens for coadministration with circumsporozoite protein to enhance vaccine efficacy.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-01040-6
- By:
- Publication type:
- Article
Neutralizing antibodies elicited in macaques recognize V3 residues on altered conformations of HIV-1 Env trimer.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-01038-0
- By:
- Publication type:
- Article
The PvRBP2b-TfR1 interaction is not essential for reticulocytes invasion by Plasmodium vivax isolates from Cambodia.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-01031-7
- By:
- Publication type:
- Article
Effect of XBB.1.5-adapted booster vaccination on the imprinting of SARS-CoV-2 immunity.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-01023-7
- By:
- Publication type:
- Article
Preclinical characterization of the Omicron XBB.1.5-adapted BNT162b2 COVID-19 vaccine.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-01013-9
- By:
- Publication type:
- Article
Mass cytometry reveals cellular correlates of immune response heterogeneity to SARS-CoV-2 vaccination in the elderly.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-01028-2
- By:
- Publication type:
- Article
Evaluation of one year immunity following rabies post-exposure prophylaxis in dog bite cases.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-01030-8
- By:
- Publication type:
- Article
Modi-2 a vaccine stimulating CD4 responses to homocitrullinated self epitopes as therapy for solid cancers.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-01029-1
- By:
- Publication type:
- Article
Author Correction: Reply to: mRNA COVID-19 vaccinations are not associated with RVO development 21 days and 12 weeks after vaccination.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Ad26.RSV.preF completely protects calves from severe respiratory disease induced by bovine RSV challenge.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-01024-6
- By:
- Publication type:
- Article
A randomized trial comparing safety, immunogenicity and efficacy of self-amplifying mRNA and adenovirus-vector COVID-19 vaccines.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-01017-5
- By:
- Publication type:
- Article
Impact of rotavirus vaccination in Malawi from 2012 to 2022 compared to model predictions.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-01008-6
- By:
- Publication type:
- Article
Potent and long-lasting humoral and cellular immunity against varicella zoster virus induced by mRNA-LNP vaccine.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-00865-5
- By:
- Publication type:
- Article
Obesity does not influence SARS-CoV-2 humoral vaccine immunogenicity.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-01022-8
- By:
- Publication type:
- Article
Author Correction: Potent and long-lasting humoral and cellular immunity against varicella zoster virus induced by mRNA-LNP vaccine.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
NHBA antibodies elicited by 4CMenB vaccination are key for serum bactericidal activity against Neisseria gonorrhoeae.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-01018-4
- By:
- Publication type:
- Article
Probing novel epitopes on the Plasmodium falciparum circumsporozoite protein for vaccine development.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-01006-8
- By:
- Publication type:
- Article
Phase 1 clinical trial of Hantaan and Puumala virus DNA vaccines delivered by needle-free injection.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-00998-7
- By:
- Publication type:
- Article
A multi-epitope subunit vaccine providing broad cross-protection against diverse serotypes of Streptococcus suis.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-01015-7
- By:
- Publication type:
- Article
A Lassa virus live attenuated vaccine candidate that is safe and efficacious in guinea pigs.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-01012-w
- By:
- Publication type:
- Article
Implications of the apparent extinction of B/Yamagata-lineage human influenza viruses.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-01010-y
- By:
- Publication type:
- Article
A highly immunogenic UVC inactivated Sabin based polio vaccine.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-00995-w
- By:
- Publication type:
- Article
Mapping global public perspectives on mRNA vaccines and therapeutics.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-01019-3
- By:
- Publication type:
- Article
Preclinical evaluation of a universal inactivated influenza B vaccine based on the mosaic hemagglutinin-approach.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-01014-8
- By:
- Publication type:
- Article
Irradiated whole cell Chlamydia vaccine confers significant protection in a murine genital tract challenge model.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-00968-z
- By:
- Publication type:
- Article
Improving precision of vaccine efficacy evaluation using immune correlate data in time-to-event models.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-00937-6
- By:
- Publication type:
- Article
Neutralization of SARS-CoV-2 KP.1, KP.1.1, KP.2 and KP.3 by human and murine sera.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-01016-6
- By:
- Publication type:
- Article
Assessing acute kidney injury risk after COVID vaccination and infection in a large cohort study.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-00964-3
- By:
- Publication type:
- Article
CRISPR/Cas9 screens identify key host factors that enhance rotavirus reverse genetics efficacy and vaccine production.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-01007-7
- By:
- Publication type:
- Article